mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels) Mar Riveiro-Barciela; Luisa Roade; Joan Martínez-Camprecios; Judit Vidal-González; Basilio Rodríguez-Diez; Manel Perelló; Guillermo Ortí; Virginia Robles-Alonso; Cristina Berastegui; Jordi Navarro; Fernando Martínez-Valle; Itxarone Bilbao; Lluis Castells; Meritxell Ventura-Cots; Jordi Llaneras; Ariadna Rando-Segura; Xavier Forns; Sabela Lens; Martín Prieto; María García-Eliz; Arkaitz Imaz; Francisco Rodríguez-Frías; Maria Buti; Rafael Esteban;

Externalised nurse-led model for hepatitis C virus microelimination and impact of drug use profile Anna Miralpeix; Paula Ibáñez; Víctor Navarro; Patricia Colomera; Montserrat Gálvez; Zoe Mariño; Xavier Major; Joan Colom; Xavier Forns; Sabela Lens;

Characterizing Hepatitis Delta in Spain and the gaps in its management Sergio Rodríguez-Tajes; Adriana Palom; Álvaro Giráldez Gallego; Antonio Moreno; Juan José Urquijo; Manuel Rodríguez; Marta Alvarez-Argüelles; Moisés Diago; María García-Eliz; Javier Fuentes; Ana María Martínez Sapiña Pérez; Pilar Castillo; Marta Casado; Elena Pérez Campos; Raquel Muñoz; Marta Hernández-Conde; Rosa María Morillas; Rafael Granados; Mireia Miquel; María Julia Morillas Ariño; Monserrat García-Retortillo; Jose Antonio Carrión; José María Moreno; Cristina Montón; Jesús Manuel González-Santiago; Sara Lorente; Joaquín Cabezas; Beatriz Mateos; Sergio Vázquez-Rodríguez; Fernando Díaz-Fontenla; José María Pinazo; Mercè Delgado; Domingo Pérez-Palacios; Diana Horta; Cristina Fernández Marcos; Carmen López; José Luis Calleja; Inmaculada Fernández; Javier García-Samaniego; Xavier Forns; María Buti; Sabela Lens;